ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/oestrogen-axis

Search results

target/oestrogen-axis
41 trial(s) found.
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (WITHDRAWN)
NA
NA
WA6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (WITHDRAWN)
3199 - Frankston - Peninsula Health Frankston Hospital (COMPLETED)
2200 - Bankstown - Bankstown-Lidcombe Hospital (WITHDRAWN)2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital (WITHDRAWN)2640 - Albury - Border Medical Oncology Research Unit (WITHDRAWN)
4066 - Auchenflower - Icon Cancer Centre at Wesley Hospital (WITHDRAWN)4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital (WITHDRAWN)
WA6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (SUSPENDED)
2076 - Wahroonga - Sydney Adventist Hospital (WITHDRAWN)2228 - Miranda - Southside Cancer Care Centre (WITHDRAWN)
NSW2050 - Camperdown - Chris O'Brien Lifehouse (TERMINATED)
2076 - Wahroonga - Sydney Adventist Hospital (COMPLETED)2485 - Tweed Heads - The Tweed Hospital (COMPLETED)2640 - Albury - Border Medical Oncology Research Unit (COMPLETED)
3000 - Melbourne - Peter MacCallum Cancer Centre (COMPLETED)3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (COMPLETED)3165 - East Bentleigh - Peter MacCallum Cancer Centre Moorabbin Campus (COMPLETED)
QLD4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (COMPLETED)
Filters
oestrogen axis
100%
ER
71%
CDK4
66%
CDK6
56%
PI3K alpha
27%
CDK4 selective
17%
androgen axis
15%
mTOR
12%
mTORC1
12%
CDK2
12%
ERBB2
10%
AR
10%
LHRH
10%
AKT
10%
VEGF
7%
PARP
7%
Trop2
7%
GnRH
7%
PI3K
5%
mTORC2
5%
PARP1-selective
5%
PD-1/PD-L1
5%
PD-L1
5%
CYP17A1
5%
Bcl2
2%
ER alpha
2%
BRAF
2%
CRAF
2%
FAK
2%
MEK
2%
RAF
2%
pan-RAF
2%
CDK7
2%
KAT6
2%
CD40
2%
IL-6
2%
LIV1
2%
HMG-CoA reductase
2%
NA